Christopher R. Fenimore - Dec 16, 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role: SVP Controller
Signature: /s/**Christopher R. Fenimore
Stock symbol: REGN
Transactions as of: Dec 16, 2022
Transactions value $: $0
Form type: 4
Date filed: 12/20/2022, 03:06 PM
Previous filing: Dec 13, 2022
Next filing: Feb 7, 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	REGN	Common Stock	Award	$0	+1.93K	+11.56%	$0.00	18.6K	Dec 16, 2022	Direct	F1
holding	REGN	Common Stock						1.78K	Dec 16, 2022	2021 GRAT
holding	REGN	Common Stock						5K	Dec 16, 2022	2022 GRAT
holding	REGN	Common Stock						1.48K	Dec 16, 2022	By 401(k) Plan
holding	REGN	Common Stock						1.9K	Dec 16, 2022	By Trust	F2
holding	REGN	Common Stock						461	Dec 16, 2022	by Trust for Daugh
holding	REGN	Common Stock						460	Dec 16, 2022	by Trust for Son

Showing 1 to 7 of 7 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	REGN	Non-Qualified Stock Option (right to buy)	Award	$0	+7.11K		$0.00	7.11K	Dec 16, 2022	Common Stock	7.11K	$726.53	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 16, 2024 and 50% on December 16, 2026.
F2	These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
F3	The stock option award vests in four equal annual installments, commencing one year after the date of grant.